Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (6) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blume, Alexander Dr. (1) Chen, Wei Prof. Dr. (1) Diecke, Sebastian Dr. (9) Falcke, Martin Prof. Dr. (1) Franke, Vedran Dr. (1) Friedrich, Corinna (1) Haucke, Volker Professor (1) Hinz, Michael Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kirchner, Marieluise Dr. (4) Kolesnichenko, Marina Dr. (1) Kühn, Ralf Dr. (1) Müthel, Stefanie (1) Ofenbauer, Andreas Dr. (1) Popp, Oliver Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (2) Suarez Artiles, Lorena Dr. (1) Tursun, Baris Dr. (1) Uyar, Bora Dr. (4) Vucicevic, Dubravka (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Wurmus, Ricardo (1) Zampieri, Niccolo Dr. (1) Zauber, Henrik Dr. (2) (-) Gerhardt, Holger Prof. Dr. (1) (-) Hirsekorn, Antje (1) (-) Lacadie, Scott Allen Dr. (1) (-) Mertins, Philipp Dr. (13) Angiogenese & Metabolismus (2) (-) Bioinformatics and Omics Data Science (3) Bioinformatik der Genregulation (7) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (7) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genom-Editierung & Krankheitsmodelle (1) Genomics (3) Immunregulation und Krebs (1) Integrative Vaskuläre Biologie (19) Magnetic Resonance (7) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (1) Molekulare Herz- Kreislaufforschung (1) (-) Pluripotent Stem Cells (2) Proteom Dynamik (3) (-) Proteomics (13) Psychoneuroimmunologie (1) RNA Biologie und Posttranscriptionale Regulation (4) Transgenics (1) Translational Bioinformatics (1) Translationale Kardiologie und Funktionelle Genomforschung (1) Zelluläre Neurowissenschaften (3) 2006 (1) 2008 (1) 2011 (1) 2012 (3) 2013 (6) 2014 (4) 2015 (6) (-) 2016 (3) 2017 (5) (-) 2018 (12) 2019 (11) 2020 (13) 2021 (12) 2022 (20) 2023 (16) 2024 (6) 15 Ergebnisse: Active Filter: Gerhardt, Holger Prof. Dr.Hirsekorn, AntjeLacadie, Scott Allen Dr.Mertins, Philipp Dr.Bioinformatics and Omics Data SciencePluripotent Stem CellsProteomics20162018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 13. September 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert 01. Juli 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr 01. Juli 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass 02. Juni 2016 / Nature Proteogenomics connects somatic mutations to signalling in breast cancer P. Mertins D.R. Mani K.V. Ruggles M.A. Gillette K.R. Clauser P. Wang X. Wang J.W. Qiao S. Cao F. Petralia E. Kawaler F. Mundt K. Krug Z. Tu J.T. Lei M.L. Gatza M. Wilkerson C.M. Perou V. Yellapantula K.L. Huang C. Lin M.D. McLellan P. Yan S.R. Davies R.R. Townsend S.J. Skates J. Wang B. Zhang C.R. Kinsinger M. Mesri H. Rodriguez L. Ding A.G. Paulovich D. Fenyoe M.J. Ellis S.A. Carr 04. März 2016 / J Proteome Res Reproducibility of differential proteomic technologies in CPTAC fractionated xenografts D.L. Tabb X. Wang S.A. Carr K.R. Clauser P. Mertins M.C. Chambers J.D. Holman J. Wang B. Zhang L.J. Zimmerman X. Chen H.P. Gunawardena S.R. Davies M.J.C. Ellis S. Li R.R. Townsend E.S. Boja K.A. Ketchum C.R. Kinsinger M. Mesri H. Rodriguez T. Liu S. Kim J.E. McDermott S.H. Payne V.A. Petyuk K.D. Rodland R.D. Smith F. Yang D.W. Chan B. Zhang H. Zhang Z. Zhang J.Y. Zhou D.C. Liebler 01. März 2016 / Mol Cell Proteomics An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer K.V. Ruggles Z. Tang X. Wang H. Grover M. Askenazi J. Teubl S. Cao M.D. McLellan K.R. Clauser D.L. Tabb P. Mertins R. Slebos P. Erdmann-Gilmore S. Li H.P. Gunawardena L. Xie T. Liu J.Y. Zhou S. Sun K.A. Hoadley C.M. Perou X. Chen S.R. Davies C.A. Maher C.R. Kinsinger K.D. Rodland H. Zhang Z. Zhang L. Ding R.R. Townsend H. Rodriguez D. Chan R.D. Smith D.C. Liebler S.A. Carr S. Payne M.J. Ellis D. Fenyö 15. Februar 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks 01. März 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton 22. Februar 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar 01. Mai 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
13. September 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert
01. Juli 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr
01. Juli 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass
02. Juni 2016 / Nature Proteogenomics connects somatic mutations to signalling in breast cancer P. Mertins D.R. Mani K.V. Ruggles M.A. Gillette K.R. Clauser P. Wang X. Wang J.W. Qiao S. Cao F. Petralia E. Kawaler F. Mundt K. Krug Z. Tu J.T. Lei M.L. Gatza M. Wilkerson C.M. Perou V. Yellapantula K.L. Huang C. Lin M.D. McLellan P. Yan S.R. Davies R.R. Townsend S.J. Skates J. Wang B. Zhang C.R. Kinsinger M. Mesri H. Rodriguez L. Ding A.G. Paulovich D. Fenyoe M.J. Ellis S.A. Carr
04. März 2016 / J Proteome Res Reproducibility of differential proteomic technologies in CPTAC fractionated xenografts D.L. Tabb X. Wang S.A. Carr K.R. Clauser P. Mertins M.C. Chambers J.D. Holman J. Wang B. Zhang L.J. Zimmerman X. Chen H.P. Gunawardena S.R. Davies M.J.C. Ellis S. Li R.R. Townsend E.S. Boja K.A. Ketchum C.R. Kinsinger M. Mesri H. Rodriguez T. Liu S. Kim J.E. McDermott S.H. Payne V.A. Petyuk K.D. Rodland R.D. Smith F. Yang D.W. Chan B. Zhang H. Zhang Z. Zhang J.Y. Zhou D.C. Liebler
01. März 2016 / Mol Cell Proteomics An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer K.V. Ruggles Z. Tang X. Wang H. Grover M. Askenazi J. Teubl S. Cao M.D. McLellan K.R. Clauser D.L. Tabb P. Mertins R. Slebos P. Erdmann-Gilmore S. Li H.P. Gunawardena L. Xie T. Liu J.Y. Zhou S. Sun K.A. Hoadley C.M. Perou X. Chen S.R. Davies C.A. Maher C.R. Kinsinger K.D. Rodland H. Zhang Z. Zhang L. Ding R.R. Townsend H. Rodriguez D. Chan R.D. Smith D.C. Liebler S.A. Carr S. Payne M.J. Ellis D. Fenyö
15. Februar 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks
01. März 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton
22. Februar 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar
01. Mai 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma